An­oth­er 4 phar­mas make the fa­bled Nas­daq leap, with com­bined raise rapid­ly ap­proach­ing $4.5B

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

The IPO train is once again full-steam ahead with four new pric­ings an­nounced af­ter mar­ket close Thurs­day.

De­sign Ther­a­peu­tics, Edge­wise Ther­a­peu­tics, Ike­na On­col­o­gy and Uni­verse Phar­ma­ceu­ti­cals are all hit­ting Nas­daq on Fri­day. The for­mer three each hauled in more than $100 mil­lion, with De­sign rais­ing $240 mil­lion, Edge­wise net­ting $176 mil­lion and Ike­na pulling off a $125 mil­lion raise. Uni­verse clocked in at $25 mil­lion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER